Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Krensavage Asset Management, LLC
Form 13F · Q2 2026

Krensavage Asset Management, LLC

CIK 1609251申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$26万
申报组合市值
18
持仓数量
12
Quarters on record
Top 50
持仓数量

Krensavage Asset Management, LLC——持仓

共 18 个持仓中的前 18 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ENTA Enanta Pharmaceuticals Inc2.9M+0.0%$4万15.9%
2JAZZ Jazz Pharmaceuticals Plc167,816+0.0%$4万15.4%
3UTHR United Therapeutics Corp Del69,282−17.8%$4万14.3%
4BMRN Biomarin Pharmaceutical Inc524,786+0.0%$3万11.4%
5EXEL Exelixis Inc370,693−10.8%$2万7.7%
6ABT Abbott Laboratories200,000+3900.0%$2万6.9%
7SNY Sanofi Sa323,946+0.0%$1万5.3%
8SUPN Supernus Pharmaceuticals280,681+0.0%$1万5.0%
9RARE Ultragenyx Pharmaceutical In390,879+0.0%$1万5.0%
10VNDA Vanda Pharmaceuticals Inc1.2M+0.0%$7,2242.7%
11BNTX Biontech Se59,523+0.0%$5,5392.1%
12GSK Gsk Plc96,729+0.0%$5,0711.9%
13BIIB Biogen Inc20,000+0.0%$4,3211.6%
14REGN Regeneron Pharmaceuticals6,000+50.0%$3,7411.4%
15EMBC Embecta Corp1.1M+54.4%$3,7011.4%
16ARDX Ardelyx Inc534,523+6.9%$2,7261.0%
17INMD Inmode Ltd120,942+0.0%$1,7680.7%
18EOLS Evolus Inc157,985+0.0%$1,0960.4%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。